Ralph Rosato, MD
Plastic and Reconstructive Surgery · Vero Beach, FLNPI 1154357762
Payments from drug & device makers
Across 51 payments — averaging $34.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$880
- AbbVie$283
- Galderma Laboratories, L.p.$261
- Mentor Worldwide LLC$176
- Boston Scientific$64
- Dilon Technologies, Inc.$48
- plus $63 from 3 others
Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$250
What the payments were for
- Speaking & faculty fees$20011%
- Food & beverage$1,57689%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 12 | $880 |
| AbbVie(2 entities) | 16 | $283 |
| Galderma Laboratories, L.p. | 5 | $261 |
| Mentor Worldwide LLC | 11 | $176 |
| Boston Scientific | 2 | $64 |
| Dilon Technologies, Inc. | 1 | $48 |
| Novartis | 2 | $26 |
| Smith+Nephew | 1 | $20 |
| Guard Medical Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,776 in reported general payments places this provider in the 35th percentile of 235 plastic and reconstructive surgery providers in Florida.
See all plastic and reconstructive surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 130 | $479 |
| Doxycycline Monohydrate | 31 | $134 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $121 |
| Ondansetron OdtOndansetron | 22 | $94 |
| Montelukast Sodium | 12 | $84 |
| Mupirocin | 13 | $79 |
| Diazepam | 18 | $34 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Vero Beach
- Alan DurkinVero Beach$549K
- Edgar SosaVero Beach$504K
- Luis AponteTampa$840K
- Sai Ramakrishna Velamuri VenkataTampa$317K
- Vaishali DoolabhJacksonville$313K
- David SmithTampa$226K
- Lee GibsteinBay Harbor Islands$216K
- John MurrayJacksonville$188K
- Arthur DesrosiersMiami$156K
- Itzhak NirLoxahatchee$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.